XML 97 R87.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Mar. 12, 2021
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Preferred stock, shares authorized (in share)   10,000,000     10,000,000   10,000,000
Preferred stock, no par value (in dollars per share)   $ 0     $ 0   $ 0
Preferred stock, shares issued (in shares)   0     0   0
Preferred stock, shares outstanding (in shares)   0     0   0
Derivative, notional amount     $ 84.1        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   400,000   800,000 500,000 800,000  
Deferred tax assets, derivative instruments   $ 20.6 $ 20.6   $ 20.6    
Convertible Debt Securities              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   3,700,000 3,700,000   3,700,000    
Common stock, conversion price (in dollars per share)   $ 126.00 $ 126.00        
Over-Allotment Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Sale of stock, number of shares issued in transaction 4,472,222            
Sale of stock, consideration received on transaction $ 389.4